A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Clinical trial NCT01152554 · COMPLETED

Trial details

NCT number: NCT01152554
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Major Depressive Disorder MDD Depression

Start date: 2010-06-01
Primary completion: 2012-02-01
Enrollment: 813

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.